Medmix : Presentation for September 2023 equities conferences_September 05 2023
September 07, 2023
Share
Investor Presentation
September 2023
medmix CONFIDENTIAL
The safe harbor statement under the
US private securities litigation reform act 1995
This presentation contains forward-looking statements that are based on management's current assumptions and expectations concerning future developments, including but not limited to, projections of financial developments, market activities or future performance of products and solutions, which therefore contain certain risks and uncertainties. These forward-looking statements are subject to change based on known or unknown risks and various other factors, which could cause the actual results or performance to differ materially from the statements made in this presentation. These risks and other factors include, among others, general economic and geopolitical conditions, foreign exchange fluctuations, competitive product and pricing pressures, the effect of a
pandemic or epidemic, a cyber event, a natural disaster or other force majeure, as well as regulatory developments and changes in tax
regimes.
Alternative Performance Measures (APM)
All bridges from reported figures to APM can be found in the financial review of medmix' half-year report 2023 and all definitions of APM can be found in the APM section of medmix' annual report 2022.
3
medmix CONFIDENTIAL
Our aspiration and mission
ASPIRATION
Be the global leader in high precision delivery devices for the healthcare, consumer and industrial end-markets
MISSION
Providing innovative solutions to help millions of people live a healthier and more confident life
4
Our values
Customer Focus
We develop, manufacture and market products and
solutions that meet our customers' needs more
effectively than the competition.
Trust and Teamwork
We build trust by an open, honest, and effective collaboration with each other.
Sustainable Innovation
We bring innovation to life by continuously improving our processes, products, and solutions while ensuring sustainability for the future.
Quality and Accountability
We strive to produce excellent work. We enjoy
solving problems and hold ourselves accountable
for solutions which deliver value to our customers.
5
Attachments
Original Link
Original Document
Permalink
Disclaimer
Medmix Ltd. published this content on 08 September 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 September 2023 12:59:08 UTC.
Medmix Systems AG is a Switzerland-based company active in manufacturing of high-precision delivery devices. The Company operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.